Peer-reviewedCC BYFrontiers in pharmacology
Safety signals and CMV-related events reported during letermovir therapy: a FAERS database study
- 1Tianjin Institutes of Health Science, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , ,
- 2College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University , ,
Related
- Patient-Reported Burden and Clinical Spectrum of Rheumatic Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy in Lung Cancer: A Real-World Cohort Study.
- Systematic analysis of echinocandin-associated adverse reactions using the FAERS database: identification of unique DRESS and resistance signals
- Safety signals of tocilizumab in pediatric patients: A real-world pharmacovigilance analysis based on the FAERS database with network pharmacology insights.
- Comparative real-world pharmacovigilance analysis of adverse event signals associated with six approved CAR-T products using the FAERS database.
- Respiratory adverse-event signals of four Bruton tyrosine kinase inhibitors: cross-database replication and temporal characterization in FAERS and JADER
BibTeX
@article{chen2026safety,
title = {{Safety signals and CMV-related events reported during letermovir therapy: a FAERS database study}},
author = {Zhangjie Chen and Shuning Zhang and Sisi Zhen and Chun Wang and Xin Chen and Sizhou Feng},
journal = {Frontiers in pharmacology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13657975},
note = {CC BY},
}
RIS
TY - JOUR
TI - Safety signals and CMV-related events reported during letermovir therapy: a FAERS database study
AU - Zhangjie Chen
AU - Shuning Zhang
AU - Sisi Zhen
AU - Chun Wang
AU - Xin Chen
AU - Sizhou Feng
PY - 2026
DA - 2026/10/16
JO - Frontiers in pharmacology
UR - https://europepmc.org/article/PMC/PMC13657975
SN - 1663-9812
ER -